Literature DB >> 7596137

Different involvement of nitric oxide in endothelium-dependent relaxation of porcine pulmonary artery and vein: influence of hypoxia.

M Félétou1, V Girard, E Canet.   

Abstract

We designed experiments to determine in vitro the influence of hypoxia on endothelium function in porcine pulmonary artery and vein. Rings of large isolated intralobar pulmonary arteries and veins were mounted in organ chambers for isometric tension recording. In veins and arteries with endothelium (precontracted with histamine and U 46619, respectively), hypoxia induced a transient contractile response that was significantly greater in veins. These contractile responses were fully blocked by L-nitro arginine (LNA) in arteries but only partially in veins. In pulmonary vessels without endothelium, only venous rings produced a contractile response to hypoxia; this contraction was blocked by indomethacin. In precontracted pulmonary arterial and venous rings, bradykinin (BK) induced endothelium-dependent relaxations unaffected by indomethacin. Venous relaxations were fully blocked by LNA, but arterial relaxations were only partially inhibited by the nitric oxide (NO) synthase inhibitor. In KCl (30 mM)-precontracted vessels, the endothelium-dependent relaxations were minimally affected in veins but significantly inhibited in arteries. Identical results were obtained in tissue contracted with histamine or U 46619 in presence of tetraethyl ammonium (TEA 10 mM). Hypoxia (30 mm Hg) abolished the venous relaxation but did not significantly influence the arterial relaxation. In arterial rings, the effects of KCl and LNA (or hypoxia) were additive. These results suggest that in isolated porcine pulmonary veins, endothelium-dependent relaxation to BK is exclusively dependent on NO formation. In arteries, however, NO production is partially involved. Another mechanism, possibly endothelium-dependent hyperpolarization, exists. These differences in endothelial responsiveness lead to different patterns of response to hypoxia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596137     DOI: 10.1097/00005344-199504000-00022

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  Activation of endothelial and epithelial K(Ca) 2.3 calcium-activated potassium channels by NS309 relaxes human small pulmonary arteries and bronchioles.

Authors:  Christel Kroigaard; Thomas Dalsgaard; Gorm Nielsen; Britt E Laursen; Hans Pilegaard; Ralf Köhler; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke.

Authors:  Yi-Je Chen; Breanna K Wallace; Natalie Yuen; David P Jenkins; Heike Wulff; Martha E O'Donnell
Journal:  Stroke       Date:  2014-12-04       Impact factor: 7.914

3.  Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone.

Authors:  Xavier Norel; Laurence Walch; Jean-Pierre Gascard; Vincent deMontpreville; Charles Brink
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

4.  Long-term effects of prenatal hypoxia on endothelium-dependent relaxation responses in pulmonary arteries of adult sheep.

Authors:  Jie Liu; Yuansheng Gao; Sewite Negash; Lawrence D Longo; J Usha Raj
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-09       Impact factor: 5.464

Review 5.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

6.  Levosimendan reduces segmental pulmonary vascular resistance in isolated perfused rat lungs and relaxes human pulmonary vessels.

Authors:  Annette Dorothea Rieg; Said Suleiman; Nina Andrea Bünting; Eva Verjans; Jan Spillner; Heike Schnöring; Sebastian Kalverkamp; Thomas Schröder; Saskia von Stillfried; Till Braunschweig; Gereon Schälte; Stefan Uhlig; Christian Martin
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

7.  Milrinone relaxes pulmonary veins in guinea pigs and humans.

Authors:  Annette D Rieg; Said Suleiman; Alberto Perez-Bouza; Till Braunschweig; Jan W Spillner; Thomas Schröder; Eva Verjans; Gereon Schälte; Rolf Rossaint; Stefan Uhlig; Christian Martin
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.